BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chedid MF, Kruel CRP, Pinto MA, Grezzana-Filho TJM, Leipnitz I, Kruel CDP, Scaffaro LA, Chedid AD. Hepatocellular carcinoma: Diagnosis and operative management. Arq Bras Cir Dig. 2017;30:272-278. [PMID: 29340553 DOI: 10.1590/0102-6720201700040011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Liu XN, Cui DN, Li YF, Liu YH, Liu G, Liu L. Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis. World J Gastroenterol 2019; 25(30): 4199-4212 [PMID: 31435173 DOI: 10.3748/wjg.v25.i30.4199] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
2 Li F, Sun X, Liu Q, Liu X, Zhang J. Long Noncoding RNA MIR100HG Knockdown Attenuates Hepatocellular Carcinoma Progression by Regulating MicroRNA-146b-5p/Chromobox 6. Gastroenterol Res Pract 2021;2021:6832518. [PMID: 34381502 DOI: 10.1155/2021/6832518] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Brunaldi VO, Brunaldi JE, Vollet-Filho JD, Brunaldi MO, Ardengh JC, Bagnato VS, Dos-Santos JS, Kemp R. Photodynamic therapy of extrahepatic cholangiocarcinoma using digital cholangioscopy. Arq Bras Cir Dig 2020;33:e1490. [PMID: 33206846 DOI: 10.1590/0102-672020190001e1490] [Reference Citation Analysis]
4 Cai Y, Du Q, Deng TH, Shen BB, Peng YM, Zeng PH, Yu SR. Huxie Huaji Ointment Induced Apoptosis of Liver Cancer Cells In Vivo and In Vitro by Activating the Mitochondrial Pathway. Evid Based Complement Alternat Med 2021;2021:9922059. [PMID: 34335843 DOI: 10.1155/2021/9922059] [Reference Citation Analysis]
5 Wang F, Qi X, Li Z, Jin S, Xie Y, Zhong H. lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma. Cancer Manag Res 2019;11:3813-28. [PMID: 31118799 DOI: 10.2147/CMAR.S197673] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
6 Jangjou A, Meisami AH, Jamali K, Niakan MH, Abbasi M, Shafiee M, Salehi M, Hosseinzadeh A, Amani AM, Vaez A. The promising shadow of microbubble over medical sciences: from fighting wide scope of prevalence disease to cancer eradication. J Biomed Sci 2021;28:49. [PMID: 34154581 DOI: 10.1186/s12929-021-00744-4] [Reference Citation Analysis]
7 Wei F. Neoadjuvant immunotherapy for resectable hepatocellular carcinoma. The Lancet Gastroenterology & Hepatology 2022;7:504. [DOI: 10.1016/s2468-1253(22)00083-8] [Reference Citation Analysis]
8 Zhao G, Liu S, Chen S, Ren Z, Li C, Bian J, Wu J, Zhou J, Zhang Y. Assessment of efficacy and safety by CalliSpheres versus HepaSpheres for drug-eluting bead transarterial chemoembolization in unresectable large hepatocellular carcinoma patients. Drug Deliv 2021;28:1356-62. [PMID: 34180755 DOI: 10.1080/10717544.2021.1943057] [Reference Citation Analysis]
9 Kaseb AO, Hasanov E, Cao HST, Xiao L, Vauthey J, Lee SS, Yavuz BG, Mohamed YI, Qayyum A, Jindal S, Duan F, Basu S, Yadav SS, Nicholas C, Sun JJ, Singh Raghav KP, Rashid A, Carter K, Chun YS, Tzeng CD, Sakamuri D, Xu L, Sun R, Cristini V, Beretta L, Yao JC, Wolff RA, Allison JP, Sharma P. Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. The Lancet Gastroenterology & Hepatology 2022. [DOI: 10.1016/s2468-1253(21)00427-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
10 Lv HC, Lv YY, Wang G, Zhang XH, Li SN, Yue XF, Lu W. Mechanism of miR-424-5p promoter methylation in promoting epithelial-mesenchymal transition of hepatocellular carcinoma cells. Kaohsiung J Med Sci 2022. [PMID: 35049148 DOI: 10.1002/kjm2.12499] [Reference Citation Analysis]
11 Ye X, Qiu R, He X, Hu Z, Zheng F, Huang X, Xie X, Chen F, Ou H, Lin G. miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F. Bioengineered 2022;13:1090-102. [PMID: 34969357 DOI: 10.1080/21655979.2021.2017628] [Reference Citation Analysis]
12 Anyasor GN, Idowu DP, Nabofa W. Evaluation of the hepatoprotective effect of oral administration of aqueous fraction of methanolic extract of Costus afer leaves during induction of hepatocellular carcinoma with diethylnitrosamine in rats. Comp Clin Pathol 2020;29:733-44. [DOI: 10.1007/s00580-020-03124-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Jung JH, Lee HJ, Kim JH, Sim DY, Im E, Kim S, Chang S, Kim SH. Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2. Cells 2020;9:E985. [PMID: 32316188 DOI: 10.3390/cells9040985] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Hou Y, Zhang G. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis. Diagn Pathol 2021;16:57. [PMID: 34218795 DOI: 10.1186/s13000-021-01118-y] [Reference Citation Analysis]
15 Cao X, Zhang J, Apaer S, Yao G, Li T. microRNA-19a-3p and microRNA-376c-3p Promote Hepatocellular Carcinoma Progression Through SOX6-Mediated Wnt/β-Catenin Signaling Pathway. Int J Gen Med 2021;14:89-102. [PMID: 33469348 DOI: 10.2147/IJGM.S278538] [Reference Citation Analysis]
16 Jiang L, Cai X, Li S, Miao Y, Yang X, Lin M, Chen L, He X, Weng Z. Hydroxyethyl Starch Curcumin Enhances Antiproliferative Effect of Curcumin Against HepG2 Cells via Apoptosis and Autophagy Induction. Front Pharmacol 2021;12:755054. [PMID: 34803697 DOI: 10.3389/fphar.2021.755054] [Reference Citation Analysis]
17 Tu C, Chen W, Wang S, Tan W, Guo J, Shao C, Wang W. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2. J Cell Mol Med 2019;23:7190-9. [PMID: 30801960 DOI: 10.1111/jcmm.14197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
18 Blidisel A, Marcovici I, Coricovac D, Hut F, Dehelean CA, Cretu OM. Experimental Models of Hepatocellular Carcinoma-A Preclinical Perspective. Cancers (Basel) 2021;13:3651. [PMID: 34359553 DOI: 10.3390/cancers13153651] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Talebi M, Talebi M, Farkhondeh T, Mishra G, İlgün S, Samarghandian S. New insights into the role of the Nrf2 signaling pathway in green tea catechin applications. Phytother Res 2021;35:3078-112. [PMID: 33569875 DOI: 10.1002/ptr.7033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
20 Pessanha I, Heitor F, Furtado E, Campos AP, Gonçalves I. Long-term survival after choriocarcinoma transmitted by liver graft: A successful report in Pediatric Transplantation. Pediatr Transplant 2021;:e14135. [PMID: 34486207 DOI: 10.1111/petr.14135] [Reference Citation Analysis]
21 Du Y, Liu D, Du Y. Recent advances in hepatocellular carcinoma therapeutic strategies and imaging-guided treatment. J Drug Target 2021;:1-15. [PMID: 34727794 DOI: 10.1080/1061186X.2021.1999963] [Reference Citation Analysis]
22 Zhang X, Liu T, Li Z, Feng Y, Corpe C, Liu S, Zhang J, He X, Liu F, Xu L, Shen L, Li S, Xia Q, Peng X, Zhou X, Chen W, Zhang X, Xu J, Wang J. Hepatomas are exquisitely sensitive to pharmacologic ascorbate (P-AscH-). Theranostics 2019;9:8109-26. [PMID: 31754384 DOI: 10.7150/thno.35378] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
23 Chao Y, Zhou D. lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma. Med Sci Monit 2019;25:6581-6. [PMID: 31475695 DOI: 10.12659/MSM.915100] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
24 Zhang J, Wang X, Li G, He J, Lu Z, Yang Y, Jiang Y, Jiang L, Li F, Liu J. COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC. Biomed Res Int 2021;2021:6648078. [PMID: 33824874 DOI: 10.1155/2021/6648078] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Wang Y, Sun L, Wang L, Liu Z, Li Q, Yao B, Wang C, Chen T, Tu K, Liu Q. Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma. Cell Death Dis 2018;9:851. [PMID: 30154476 DOI: 10.1038/s41419-018-0937-7] [Cited by in Crossref: 64] [Cited by in F6Publishing: 74] [Article Influence: 16.0] [Reference Citation Analysis]
26 Li Q, Xiong DL, Wang H, Jin WL, Ma YY, Fan XM. High Expression of SLC41A3 Correlates with Poor Prognosis in Hepatocellular Carcinoma. Onco Targets Ther 2021;14:2975-88. [PMID: 33981147 DOI: 10.2147/OTT.S296187] [Reference Citation Analysis]
27 Liu B, Zhu X, Gao S, Guo J, Wang X, Cao G, Zhu L, Liu P, Xu H, Chen H, Zhang X, Liu S, Kou F. Safety and efficacy of hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin post-transarterial chemoembolization for unresectable hepatocellular carcinoma. J Interv Med 2019;2:91-6. [PMID: 34805879 DOI: 10.1016/j.jimed.2019.07.006] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Zhou H, Fu LX, Li L, Chen YY, Zhu HQ, Zhou JL, Lv MX, Gan RZ, Zhang XX, Liang G. The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression. J Ethnopharmacol 2020;261:113118. [PMID: 32621953 DOI: 10.1016/j.jep.2020.113118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Bao H, Muge Q. Anticancer effect of myristicin on hepatic carcinoma and related molecular mechanism. Pharm Biol 2021;59:1126-32. [PMID: 34410900 DOI: 10.1080/13880209.2021.1961825] [Reference Citation Analysis]
30 Liu X, Cui D, Li Y, Liu Y, Liu G, Liu L. Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis. WJG 2019;25:4199-212. [DOI: 10.3748/wjg.v25.i29.4199] [Cited by in CrossRef: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Maruyama H, Shiina S. Collaterals in portal hypertension: anatomy and clinical relevance. Quant Imaging Med Surg 2021;11:3867-81. [PMID: 34341755 DOI: 10.21037/qims-20-1328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Gao Y, Gu J, Wang Y, Fu D, Zhang W, Zheng G, Wang X. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137. Pathol Res Pract 2020;216:152981. [PMID: 32527447 DOI: 10.1016/j.prp.2020.152981] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Shao L, Ye Q, Jia M. miR-130-3p Promotes MTX-Induced Immune Killing of Hepatocellular Carcinoma Cells by Targeting EPHB4. J Healthc Eng 2021;2021:4650794. [PMID: 34336153 DOI: 10.1155/2021/4650794] [Reference Citation Analysis]
34 Sun C, Huang S, Wang H, Xie R, Zhang L, Zhou Q, He X, Ju W. Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma. Mol Carcinog 2019;58:2266-75. [PMID: 31523845 DOI: 10.1002/mc.23114] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
35 Hu M, Fan Z, Han Y. Effect of Perioperative Comprehensive Nursing Intervention on Transcatheter Arterial Chemoembolization in Patients with Primary Hepatic Carcinoma. Evid Based Complement Alternat Med 2022;2022:9000331. [PMID: 35815267 DOI: 10.1155/2022/9000331] [Reference Citation Analysis]
36 O'Neill L, Guinan E, Doyle S, Connolly D, O'Sullivan J, Bennett A, Sheill G, Segurado R, Knapp P, Fairman C, Normand C, Geoghegan J, Conlon K, Reynolds JV, Hussey J. Rehabilitation strategies following oesophagogastric and Hepatopancreaticobiliary cancer (ReStOre II): a protocol for a randomized controlled trial. BMC Cancer 2020;20:415. [PMID: 32404096 DOI: 10.1186/s12885-020-06889-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Dadfar SMM, Sekula-Neuner S, Trouillet V, Liu HY, Kumar R, Powell AK, Hirtz M. Evaluation of click chemistry microarrays for immunosensing of alpha-fetoprotein (AFP). Beilstein J Nanotechnol 2019;10:2505-15. [PMID: 31921529 DOI: 10.3762/bjnano.10.241] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Cho CW, Kim JM, Lee BH, Lee DS, Yun SS, Choi GS, Joh JW. Clinical impact of anatomical resection on long-term outcomes after hepatectomy for primary solitary hepatocellular carcinoma with or without preoperative positron emission tomography positivity. Ann Transl Med 2020;8:1377. [PMID: 33313122 DOI: 10.21037/atm-20-1583] [Reference Citation Analysis]
39 He J, Yu J. Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A. Biosci Rep 2019;39:BSR20192550. [PMID: 31696213 DOI: 10.1042/BSR20192550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]